Literature DB >> 18361927

Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature.

Sean Garrean1, Justin Hering, Abdul Saied, W Scott Helton, N Joseph Espat.   

Abstract

BACKGROUND: Surgical resection is the treatment of choice for hepatic tumors; however, for various reasons, the vast majority of patients are not operative candidates. As a result, several local ablative therapies have emerged as alternatives to resection or as adjuncts in total oncologic care. Presently, the most widely employed liver-directed treatment is radiofrequency thermal ablation.
METHODS: To define the current status of radiofrequency ablation (RFA), the authors reviewed available safety and efficacy data from select studies on RFA. A MEDLINE search was performed using the keywords "tumor type" + "radiofrequency ablation" + "survival." Only those studies containing long-term survival data on greater than 50 patients were included in this analysis.
CONCLUSIONS: Although RFA has been readily adopted into treatment paradigms, more rigorous trials are needed to solidify its place in the armamentarium of therapeutic strategies for hepatic malignancy.

Entities:  

Mesh:

Year:  2008        PMID: 18361927     DOI: 10.1016/j.amjsurg.2007.06.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  36 in total

1.  Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung.

Authors:  Christopher L Brace; Teresa A Diaz; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-05-27       Impact factor: 3.464

2.  External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy.

Authors:  Mashaal Dhir; Srinevas K Reddy; Lynette M Smith; Fred Ullrich; James Wallis Marsh; Allan Tsung; David A Geller; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

3.  What, how, and when to offer nonresectional therapy for colorectal cancer liver metastases.

Authors:  Cherif Boutros; N Joseph Espat
Journal:  J Gastrointest Surg       Date:  2011-01-25       Impact factor: 3.452

4.  Interactive multi-criteria planning for radiofrequency ablation.

Authors:  Christian Schumann; Christian Rieder; Sabrina Haase; Katrin Teichert; Philipp Süss; Peter Isfort; Philipp Bruners; Tobias Preusser
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-23       Impact factor: 2.924

Review 5.  Endoscopic Radiofrequency Ablation of the Pancreas.

Authors:  Tarun Rustagi; Ankit Chhoda
Journal:  Dig Dis Sci       Date:  2017-02-03       Impact factor: 3.199

Review 6.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

7.  Thermal tumor ablation therapy for colorectal cancer hepatic metastasis.

Authors:  Sanjay Munireddy; Steven Katz; P Somasundar; N Joseph Espat
Journal:  J Gastrointest Oncol       Date:  2012-03

Review 8.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

9.  Theoretical modeling for hepatic microwave ablation.

Authors:  Punit Prakash
Journal:  Open Biomed Eng J       Date:  2010-02-04

10.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.

Authors:  Maria Franca Meloni; Anita Andreano; Paul F Laeseke; Tito Livraghi; Sandro Sironi; Fred T Lee
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.